CoChat

Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor–Positive and -Negative Breast Cancer: a Nested Case–Control Study

Open access
James, Rebecca E., Lukanova, Annekatrin, Dossus, Laure, Becker, Susen, Rinaldi, Sabina, Tjønneland, Anne, Olsen, Anja, Overvad, Kim, Mesrine, Sylvie, Engel, Pierre, Clavel-Chapelon, Françoise, Chang-Claude, Jenny, Vrieling, Alina, Boeing, Heiner, Schütze, Madlen, Trichopoulou, Antonia, Lagiou, Pagona, Trichopoulos, Dimitrios, Palli, Domenico, Krogh, Vittorio, Panico, Salvatore, Tumino, Rosario, Sacerdote, Carlotta, Rodríguez, Laudina, Buckland, Genevieve, Sánchez, Maria-José, Amiano, Pilar, Ardanaz, Eva, Bueno-de-Mesquita, Bas, Ros, Martine M., van Gils, Carla H., Peeters, Petra H., Khaw, Kay-Tee, Wareham, Nick, Key, Timothy J., Allen, Naomi E., Romieu, Isabelle, Siddiq, Afshan, Cox, David, Riboli, Elio, Kaaks, Rudolf · 2011 · Cancer Prevention Research
Cited by 122

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Prediagnostic endogenous sex steroid hormone levels have well established associations with overall risk of breast cancer. While evidence toward the existence of distinct subtypes of breast cancer accumulates, few studies have investigated the associations of sex steroid hormone levels with risk of hormone receptor [estrogen receptor (ER) and/or progesterone receptor (PR)] defined breast cancer. In a case–control study nested within the EPIC cohort (European Prospective Investigation into Cancer and Nutrition), estradiol, testosterone, and sex hormone–binding globulin levels were measured in prediagnostic serum samples from postmenopausal women not using hormone replacement therapy at blood donation. A total of 554 women who developed invasive breast cancer with information on receptor status were matched with 821 control subjects. Conditional logistic regression models estimated breast cancer risk with hormone concentrations according to hormone receptor status of the tumor. Sex steroid hormones were associated with risks of not only ER+PR+ breast cancer [estradiol OR for highest vs. lowest tertile = 2.91 (95% CI: 1.62–5.23), Ptrend = 0.002; testosterone OR = 2.27 (95% CI: 1.35–3.81), Ptrend = 0.002] but also of ER-PR- breast cancer [estradiol OR = 2.11 (95% CI: 1.00–4.46), Ptrend = 0.05; testosterone OR = 2.06 (95% CI: 0.95–4.46), Ptrend = 0.03], with associations appearing somewhat stronger in the receptor-positive disease. Serum androgens and estrogens are associated with risks of both hormone receptor–negative as well as receptor–positive breast tumors. Further research is needed to establish through which molecular pathways, and during which evolutionary stages of development, androgens and estrogens can promote the occurrence of both receptor-positive and -negative clinical breast tumors. Cancer Prev Res; 4(10); 1626–35. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1940-6207.capr-11-0090

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 122

Metadata

Authors
James, R. E., Lukanova, A., Dossus, L., Becker, S., Rinaldi, S., Tjønneland, A., Olsen, A., Overvad, K., Mesrine, S., Engel, P., Clavel-Chapelon, F., Chang-Claude, J., Vrieling, A., Boeing, H., Schütze, M., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Palli, D., Krogh, V., Panico, S., Tumino, R., Sacerdote, C., Rodríguez, L., Buckland, G., Sánchez, M.-J., Amiano, P., Ardanaz, E., Bueno-de-Mesquita, B., Ros, M. M., van Gils, C. H., Peeters, P. H., Khaw, K.-T., Wareham, N., Key, T. J., Allen, N. E., Romieu, I., Siddiq, A., Cox, D., Riboli, E., & Kaaks, R.
Venue
Cancer Prevention Research
Published
2011-10-01
Volume
4
Issue
10
Pages
1626-1635
ISSN
  • 1940-6207 (ISSN-L)
  • 1940-6215
OpenAlex
W2114836367
Cited by
122
References
5
FWCI
6.76
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor–Positive and -Negative Breast Cancer: a Nested Case–Control Study. https://app.cochat.ai/papers/10.1158/1940-6207.capr-11-0090
The paper
James, R. E., Lukanova, A., Dossus, L., Becker, S., Rinaldi, S., Tjønneland, A., Olsen, A., Overvad, K., Mesrine, S., Engel, P., Clavel-Chapelon, F., Chang-Claude, J., Vrieling, A., Boeing, H., Schütze, M., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Palli, D., . . . Kaaks, R. (2011). Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor–Positive and -Negative Breast Cancer: a Nested Case–Control Study. Cancer Prevention Research. https://doi.org/10.1158/1940-6207.capr-11-0090

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.